Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury

Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astroglios...

Full description

Bibliographic Details
Main Authors: Tetsu Kimura, Yuta Horikoshi, Chika Kuriyagawa, Yukitoshi Niiyama
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/21/11573
_version_ 1797512434788859904
author Tetsu Kimura
Yuta Horikoshi
Chika Kuriyagawa
Yukitoshi Niiyama
author_facet Tetsu Kimura
Yuta Horikoshi
Chika Kuriyagawa
Yukitoshi Niiyama
author_sort Tetsu Kimura
collection DOAJ
description Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astrogliosis, and axon growth inhibition in IS and SCI. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), were previously considered to be non-functional. However, they have attracted much attention because they play an essential role in regulating gene expression in physiological and pathological conditions. There is growing evidence that ROCK inhibitors, such as fasudil and VX-210, can reduce injury in IS and SCI in animal models and clinical trials. Recently, it has been reported that miRNAs are decreased in IS and SCI, while lncRNAs are increased. Inhibiting the Rho/ROCK pathway with miRNAs alleviates apoptosis, neuroinflammation, oxidative stress, and axon growth inhibition in IS and SCI. Further studies are required to explore the significance of ncRNAs in IS and SCI and to establish new strategies for preventing and treating these devastating diseases.
first_indexed 2024-03-10T06:01:46Z
format Article
id doaj.art-825ffe2bb9ec48eb8412a7d27adc8b16
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T06:01:46Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-825ffe2bb9ec48eb8412a7d27adc8b162023-11-22T20:54:25ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-10-0122211157310.3390/ijms222111573Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord InjuryTetsu Kimura0Yuta Horikoshi1Chika Kuriyagawa2Yukitoshi Niiyama3Department of Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine, Akita 010-8543, JapanDepartment of Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine, Akita 010-8543, JapanDepartment of Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine, Akita 010-8543, JapanDepartment of Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine, Akita 010-8543, JapanIschemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astrogliosis, and axon growth inhibition in IS and SCI. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), were previously considered to be non-functional. However, they have attracted much attention because they play an essential role in regulating gene expression in physiological and pathological conditions. There is growing evidence that ROCK inhibitors, such as fasudil and VX-210, can reduce injury in IS and SCI in animal models and clinical trials. Recently, it has been reported that miRNAs are decreased in IS and SCI, while lncRNAs are increased. Inhibiting the Rho/ROCK pathway with miRNAs alleviates apoptosis, neuroinflammation, oxidative stress, and axon growth inhibition in IS and SCI. Further studies are required to explore the significance of ncRNAs in IS and SCI and to establish new strategies for preventing and treating these devastating diseases.https://www.mdpi.com/1422-0067/22/21/11573strokespinal cord injuryRhoRho kinasenoncoding RNAapoptosis
spellingShingle Tetsu Kimura
Yuta Horikoshi
Chika Kuriyagawa
Yukitoshi Niiyama
Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
International Journal of Molecular Sciences
stroke
spinal cord injury
Rho
Rho kinase
noncoding RNA
apoptosis
title Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_full Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_fullStr Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_full_unstemmed Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_short Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_sort rho rock pathway and noncoding rnas implications in ischemic stroke and spinal cord injury
topic stroke
spinal cord injury
Rho
Rho kinase
noncoding RNA
apoptosis
url https://www.mdpi.com/1422-0067/22/21/11573
work_keys_str_mv AT tetsukimura rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury
AT yutahorikoshi rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury
AT chikakuriyagawa rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury
AT yukitoshiniiyama rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury